Fig. 1From: Cost-effectiveness analysis of a universal mass vaccination program with a PHiD-CV 2+1 schedule in MalaysiaModel structure. PHiD-CV pneumococcal polysaccharide and NTHi protein D conjugate vaccine, PCV13 13-valent pneumococcal conjugate vaccine, AOM acute otitis media, GP general practitionerBack to article page